Temporary surgical ventricular assist device for treatment of acute myocardial infarction and refractory cardiogenic shock in the percutaneous device era

Singh, Sameer K.; Witer, Lucas; Kaku, Yuji; Masoumi, Amirali; Fried, Justin; Yuzefpolskaya, M.; Colombo, P.C.; Sayer, Gabriel; Uriel, Nir; Naka, Yoshifumi; Takayama, Hiroo; Takeda, Koji

doi:10.1007/s10047-020-01236-2

Cited by 4 publications

(2 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Among them, Prof Takayama Hiroo, together with Prof Naka Yoshifumi and Prof Takeda Koji, published the most papers, and the main research content of them was on the role of cardiac assist devices of MB and MI and cardiogenic shock as well as cardiogenic shock. [17][18][19]…”

Section: General Informationmentioning

confidence: 99%

A bibliometric analysis of myocardial bridge combined with myocardial infarction

Zhang,

Cao

2024

Medicine

View full text Add to dashboard Cite

Background: The aim of this study is to analyze the process and frontiers of research in myocardial bridges (MB) to identify future research directions in the last 3 decades. Methods: Relevant literature on MB combined with myocardial infarction (MI) was searched from 1991 to 2023 in the Web of Science database, and was analyzed by bibliometric analysis using VOSviewer, CiteSpace, and the R package “bibliometrix.” Results: A total of 1233 English articles were included in this study. The number of published articles showed an increasing trend yearly. From 2017 to 2022, the annual publication volume rose rapidly, and in 2021 the publication volume even reached 95 articles, which was the highest in all years. These publications were from 68 countries and 1854 institutions, with the leading country being the U.S. and the leading institution being Columbia University. Myoho Clinical International has a close collaborative relationship with Columbia University, while in recent years, the Harvard Medical School has explored the study of MB combined with MI. Annals of Thoracic Surgery was the journal with the highest number of publications, and Takayama Hiroo and Naka Yoshifumi were the authors with the highest number of publications. The most common keywords were MI, cardiogenic shock, and MB. Conclusions: Our findings can help researchers explore the current status of MB combined with MI research and choose new survey routes for upcoming studies. Prevalence and prognosis, mechanism of MB combined with MI and molecular mechanism may become the focus of future research. In addition, more research and cooperation are needed worldwide.

show abstract

Section: General Informationmentioning

confidence: 99%

A bibliometric analysis of myocardial bridge combined with myocardial infarction

Zhang,

Cao

2024

Medicine

View full text Add to dashboard Cite

show abstract

“…The main cause of death in patients with AMI is cardiogenic shock [155,156]. Therefore, it was important to detect how KCOs affect cardiac contractility in I/R of the heart.…”

Section: Katp Channels and Cardiac Contractilitymentioning

confidence: 99%

K_ATP channels are regulators of programmed cell death and targets for the creation of novel drugs against ischemia/reperfusion cardiac injury

Maslov

Popov

Naryzhnaya

et al. 2023

Fundamemntal Clinical Pharma

View full text Add to dashboard Cite

BackgroundThe use of percutaneous coronary intervention (PCI) in patients with ST‐segment elevation myocardial infarction (STEMI) is associated with a mortality rate of 5%–7%. It is clear that there is an urgent need to develop new drugs that can effectively prevent cardiac reperfusion injury. ATP‐sensitive K+ (KATP) channel openers (KCOs) can be classified as such drugs.ResultsKCOs prevent irreversible ischemia and reperfusion injury of the heart. KATP channel opening promotes inhibition of apoptosis, necroptosis, pyroptosis, and stimulation of autophagy. KCOs prevent the development of cardiac adverse remodeling and improve cardiac contractility in reperfusion. KCOs exhibit antiarrhythmic properties and prevent the appearance of the no‐reflow phenomenon in animals with coronary artery occlusion and reperfusion. Diabetes mellitus and a cholesterol‐enriched diet abolish the cardioprotective effect of KCOs. Nicorandil, a KCO, attenuates major adverse cardiovascular event and the no‐reflow phenomenon, reduces infarct size, and decreases the incidence of ventricular arrhythmias in patients with acute myocardial infarction.ConclusionThe cardioprotective effect of KCOs is mediated by the opening of mitochondrial KATP (mitoKATP) and sarcolemmal KATP (sarcKATP) channels, triggered free radicals' production, and kinase activation.

show abstract

Characteristics of High-Performing Hospitals in Cardiogenic Shock Following Acute Myocardial Infarction

Saha,

Li,

de Lemos

et al. 2024

The American Journal of Cardiology

View full text Add to dashboard Cite

Temporary surgical ventricular assist device for treatment of acute myocardial infarction and refractory cardiogenic shock in the percutaneous device era

Cited by 4 publications

References 22 publications

A bibliometric analysis of myocardial bridge combined with myocardial infarction

A bibliometric analysis of myocardial bridge combined with myocardial infarction

K_ATP channels are regulators of programmed cell death and targets for the creation of novel drugs against ischemia/reperfusion cardiac injury

Characteristics of High-Performing Hospitals in Cardiogenic Shock Following Acute Myocardial Infarction

Contact Info

Product

Resources

About

Temporary surgical ventricular assist device for treatment of acute myocardial infarction and refractory cardiogenic shock in the percutaneous device era

Cited by 4 publications

References 22 publications

A bibliometric analysis of myocardial bridge combined with myocardial infarction

A bibliometric analysis of myocardial bridge combined with myocardial infarction

KATP channels are regulators of programmed cell death and targets for the creation of novel drugs against ischemia/reperfusion cardiac injury

Characteristics of High-Performing Hospitals in Cardiogenic Shock Following Acute Myocardial Infarction

Contact Info

Product

Resources

About

K_ATP channels are regulators of programmed cell death and targets for the creation of novel drugs against ischemia/reperfusion cardiac injury